#1 Clinical Trials Search in Europe

Glipizide

Glipizide is a medication commonly used to treat type 2 diabetes. This article examines various clinical trials that have investigated the effectiveness and safety of glipizide for managing blood sugar levels in diabetic patients. The trials cover different aspects of glipizide use, including comparisons with other diabetes medications, its effects in elderly patients and those with kidney disease, and its impact on liver and heart health.

Table of Contents

What is Glipizide?

Glipizide is a medication used to treat type 2 diabetes mellitus. It belongs to a class of drugs called sulfonylureas. Glipizide is also known by brand names such as Glucotrol and Glucotrol XL[1]. This medication helps control blood sugar levels in people with diabetes by stimulating the pancreas to produce more insulin[1].

What Conditions Does Glipizide Treat?

Glipizide is primarily used to treat:

  • Type 2 Diabetes Mellitus: This is a condition where your body doesn’t use insulin properly, leading to high blood sugar levels[1].
  • Hyperglycemia: This refers to high blood sugar levels, which is a common problem in diabetes[2].

In some cases, glipizide may also be used in patients with:

  • Chronic Kidney Disease: Some studies have explored its use in patients with diabetes who also have kidney problems[3].
  • End-Stage Renal Disease: Research has been conducted on using glipizide in diabetic patients undergoing dialysis[4].

How Does Glipizide Work?

Glipizide works by stimulating the pancreas to produce more insulin. Insulin is a hormone that helps your body use glucose (sugar) for energy. By increasing insulin production, glipizide helps lower blood sugar levels[1]. This medication is part of a group of drugs called insulin secretagogues, which means they promote insulin secretion[1].

Dosage Forms and Administration

Glipizide comes in different forms and dosages:

  • Immediate-release tablets: These are usually taken once or twice daily, often before meals[1].
  • Extended-release tablets (Glucotrol XL): These are designed to release the medication slowly over time and are typically taken once daily[2].

The dosage can range from 2.5 mg to 20 mg per day, depending on the patient’s needs and response to the medication[4]. It’s important to take glipizide exactly as prescribed by your doctor.

Effectiveness of Glipizide

Glipizide has been shown to be effective in lowering blood sugar levels in people with type 2 diabetes. Its effectiveness is often measured by changes in hemoglobin A1c (HbA1c), which is a measure of average blood sugar levels over the past 2-3 months[4].

Studies have shown that glipizide can significantly reduce HbA1c levels, with some patients achieving target blood sugar levels[4]. However, the effectiveness can vary from person to person, and your doctor will monitor your response to the medication.

Potential Side Effects

Like all medications, glipizide can cause side effects. The most common and important side effect to be aware of is:

  • Hypoglycemia: This is when your blood sugar drops too low. Symptoms can include shakiness, dizziness, sweating, and confusion[4].

Other potential side effects may include weight gain and gastrointestinal issues. It’s important to discuss any side effects you experience with your healthcare provider.

Use in Special Populations

Glipizide may be used in certain special populations, but with caution:

  • Elderly patients: Older adults may be more sensitive to the effects of glipizide and may require lower doses[1].
  • Patients with kidney disease: Glipizide has been studied in patients with chronic kidney disease, but close monitoring is required[3].
  • Patients on dialysis: Some research has explored the use of glipizide in patients with end-stage renal disease who are on dialysis[4].

Comparisons with Other Medications

Several studies have compared glipizide to other diabetes medications:

  • Glipizide vs. Alogliptin: A study compared these medications in elderly diabetic patients, looking at their effectiveness and safety[1].
  • Glipizide vs. Sitagliptin: Research has compared these drugs in patients with diabetes and end-stage renal disease[4].
  • Glipizide vs. Acarbose: A study looked at how these medications affect intestinal health and hormone levels in diabetic patients[5].

Ongoing Research

Research on glipizide is ongoing, with studies exploring various aspects of its use:

  • Genetic factors: Some research is looking at how genetic variations might affect how people respond to glipizide[6].
  • Combination therapies: Studies are exploring how glipizide works when combined with other diabetes medications[7].
  • Effects on heart health: Researchers are investigating how glipizide might affect heart function and fat around the heart[8].

These ongoing studies help doctors better understand how to use glipizide effectively and safely in different patient populations.

Aspect Details
Primary Use Treatment of type 2 diabetes
Mechanism of Action Stimulates pancreas to produce more insulin
Comparison Studies Compared with newer medications like alogliptin, sitagliptin, and exenatide
Special Populations Studied in elderly patients and those with chronic kidney disease
Key Outcomes Measured Changes in HbA1c, fasting plasma glucose, hypoglycemia incidence
Safety Considerations Monitoring for hypoglycemia and other adverse events
Additional Research Areas Effects on liver fat, heart function, and intestinal microbiome

FAQ

  • What is glipizide used for? Glipizide is primarily used to treat type 2 diabetes. It helps lower blood sugar levels by stimulating the pancreas to produce more insulin.
  • How does glipizide compare to newer diabetes medications? Clinical trials have compared glipizide to newer medications like alogliptin and sitagliptin. These studies aim to determine which drugs are more effective at controlling blood sugar and have fewer side effects, especially in specific patient groups like the elderly or those with kidney disease.
  • Are there any special considerations for using glipizide in elderly patients? Yes, one trial specifically looked at the use of glipizide in elderly diabetic patients aged 65 to 90 years. The study compared glipizide to alogliptin to evaluate efficacy and safety in this age group, as older patients may be more sensitive to medication effects.
  • Can glipizide be used in patients with kidney disease? Some trials have examined the use of glipizide in patients with chronic kidney disease and end-stage renal disease. These studies aim to determine the safety and effectiveness of glipizide in patients with impaired kidney function, as this can affect how the body processes medications.
  • What are some potential side effects of glipizide? Common side effects of glipizide may include hypoglycemia (low blood sugar). Clinical trials often monitor for adverse events, including symptomatic hypoglycemia, to assess the safety profile of glipizide compared to other diabetes medications.

Ongoing Clinical Trials on Glipizide

  • Study on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control

    Not recruiting

    3 1 1
    Investigated drugs:
    Poland

Glossary

  • Glipizide: A medication used to treat type 2 diabetes that belongs to the class of drugs called sulfonylureas. It works by stimulating the pancreas to produce more insulin.
  • Hemoglobin A1c (HbA1c): A blood test that measures average blood sugar levels over the past 2-3 months. It is expressed as a percentage and is used to diagnose and monitor diabetes.
  • Fasting Plasma Glucose (FPG): A blood test that measures blood sugar levels after an overnight fast. It is used to diagnose and monitor diabetes.
  • Hypoglycemia: A condition characterized by abnormally low blood sugar levels, which can cause symptoms such as shakiness, dizziness, and confusion.
  • Chronic Kidney Disease (CKD): A condition characterized by gradual loss of kidney function over time, which can affect how medications are processed in the body.
  • End-Stage Renal Disease (ESRD): The final stage of chronic kidney disease where the kidneys no longer function well enough to meet the body's needs, typically requiring dialysis or kidney transplant.
  • Incretin: A type of hormone produced in the gut that stimulates the production of insulin, helping to regulate blood sugar levels.
  • Alogliptin: A newer type of diabetes medication that belongs to the class of drugs called DPP-4 inhibitors, which work by increasing incretin levels.
  • Sitagliptin: Another DPP-4 inhibitor used to treat type 2 diabetes by increasing incretin levels and improving blood sugar control.
  • Acarbose: An alpha-glucosidase inhibitor used to treat diabetes by slowing the digestion of carbohydrates in the intestines, which helps control blood sugar levels after meals.

References

  1. https://clinicaltrials.gov/study/NCT00707993
  2. https://clinicaltrials.gov/study/NCT00550329
  3. https://clinicaltrials.gov/study/NCT02608177
  4. https://clinicaltrials.gov/study/NCT00509236
  5. https://clinicaltrials.gov/study/NCT01758471
  6. https://clinicaltrials.gov/study/NCT01082796
  7. https://clinicaltrials.gov/study/NCT00732524
  8. https://clinicaltrials.gov/study/NCT04167761